Previous Study: TRIO031
Next Study: TRIO038
Studies & Results
TRIO036
A Trial to Assess the Safety, Pharmacodynamic Effects, Pharmacokinetics and Efficacy of the MNK Inhibitor Tomivosertib (eFT508) in Combination with Paclitaxel, Following a Run-in Period of Tomivosertib Monotherapy, in Patients with Advanced Breast Cancer.
View FDA Study
For information on any of TRIO's clinical trials, please contact Valérie Bee, Director Project Management at valerie.bee@trioncology.org
For information on any of TRIO's clinical trials, please contact Valérie Bee, Director Project Management at valerie.bee@trioncology.org